Home/Filings/4/0001209191-23-017882
4//SEC Filing

MCCOURT Thomas A 4

Accession 0001209191-23-017882

CIK 0001446847other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 5:09 PM ET

Size

7.4 KB

Accession

0001209191-23-017882

Insider Transaction Report

Form 4
Period: 2023-03-08
MCCOURT Thomas A
Chief Commercial Officer
Transactions
  • Award

    Class A Common Stock

    2023-03-08+240,595888,193 total
  • Award

    Performance-based Restricted Stock Units

    2023-03-08+120,297120,297 total
    Exp: 2026-02-28Class A Common Stock (120,297 underlying)
Footnotes (2)
  • [F1]The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
  • [F2]Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001478448

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 5:09 PM ET
Size
7.4 KB